Benzinga
Benzinga
Benzinga
lundi, septembre 28

Encompass Health Corp

EHCNYSE
Trade with Public
Trade with Public
$123.47
À la clôture: Sep 28, 5:00 PM EST
$123.47
N/A
Après les heures: Sep 25, 4:00 PM EST
Dividende: La date ex-dividende est le dans 3 jours
AperçuActualitésPrévisions de résultatsÉvénementsObjectifs de coursDonnées financièresSentimentActionnariatDividendesComparerOptionsRapport sur les stocks

Encompass Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for Encompass Health (EHC).

Price Target Range — 12 Quarters

Analyst Consensus — 11 Analysts

1S.Buy
10Buy
Consensus RatingBuy# Analysts11Avg. Consensus PT$130Upside to Avg. PT+4.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →
DateFirmAnalystActionRating ChangePrice Target
Aug 10, 2026TD CowenRyan LangstonPT RaiseBuy$125→$140
Aug 7, 2026UBSA.J. RicePT RaiseBuy$150→$155
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
TD Cowen Maintains Buy on Encompass Health, Raises Price Target to $140

TD Cowen analyst Ryan Langston maintains Encompass Health (NYSE:EHC) with a Buy and raises the price target from $125 to $140.
Benzinga Newsdesk

PRO
UBS Maintains Buy on Encompass Health, Raises Price Target to $155

UBS analyst A.J. Rice maintains Encompass Health (NYSE:EHC) with a Buy and raises the price target from $150 to $155.
Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on Encompass Health, Raises Price Target to $150

Truist Securities analyst David Macdonald maintains Encompass Health (NYSE:EHC) with a Buy and raises the price target from $140 to $150.
Benzinga Newsdesk

PRO
Barclays Maintains Overweight on Encompass Health, Raises Price Target to $144

Barclays analyst Andrew Mok maintains Encompass Health (NYSE:EHC) with a Overweight and raises the price target from $140 to $144.
Benzinga Newsdesk

PRO
TD Cowen Initiates Coverage On Encompass Health with Buy Rating, Announces Price Target of $125

TD Cowen analyst Ryan Langston initiates coverage on Encompass Health (NYSE:EHC) with a Buy rating and announces Price Target of $125.
Benzinga Newsdesk

PRO
Barclays Maintains Overweight on Encompass Health, Lowers Price Target to $140

Barclays analyst Andrew Mok maintains Encompass Health (NYSE:EHC) with a Overweight and lowers the price target from $153 to $140.
Benzinga Newsdesk

Données et API: API Benzinga · API d'actualités boursières · API de notations d'analystes · API de logo d'entreprise

Données de marché fournies par API Benzinga

Benzinga

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

© 2026 Benzinga | All Rights Reserved